Shopping Cart
Remove All
Your shopping cart is currently empty
17(S)-HETE is an arachidonic acid metabolite generated via the CYP450 pathway. 17(S)-HETE acts as an allosteric activator of CYP450 1B1 and an ATPase inhibitor, capable of inducing cardiac hypertrophy.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 μg | $529 | 35 days | 35 days | |
| 50 μg | $987 | 35 days | 35 days | |
| 100 μg | $1,890 | 35 days | 35 days |
| Description | 17(S)-HETE is an arachidonic acid metabolite generated via the CYP450 pathway. 17(S)-HETE acts as an allosteric activator of CYP450 1B1 and an ATPase inhibitor, capable of inducing cardiac hypertrophy. |
| In vitro | 17(S)-HETE (5-20 μM) can promote the activity and protein expression of CY1B1, ultimately accelerating the process of cardiac hypertrophy in Homo sapiens [1]. |
| In vivo | After administering 17(S)-HETE (1-20 μg) via arterial injection to New Zealand white rabbits, the ATPase activity in their proximal renal tubules was significantly inhibited [2]. |
| Molecular Weight | 320.47 |
| Formula | C20H32O3 |
| Cas No. | 183509-25-3 |
| Smiles | C(=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O)\C[C@H](CCC)O |
| Color | Transparent |
| Appearance | Liquid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | 0.1 M Na2CO3: 1.00 mg/mL (3.12 mM), Sonication is recommended. PBS (pH 7.2): 0.40 mg/mL (1.25 mM), Sonication is recommended. Ethanol: Miscible DMSO: Miscible DMF: Miscible | ||||||||||
Solution Preparation Table | |||||||||||
PBS (pH 7.2)/0.1 M Na2CO3
| |||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.